Pharmaceuticals

Session 651 - Modeling in the Pharmaceutical Industry II
The development of pharmaceuticals involves the development of both process and chemistry/formulation to produce the active pharmaceutical ingredient/final drug product. We invite contributions from industry and academia that address system-level process simulation (cycle time analysis, mass and energy balances, equipment usage, scheduling etc.) and/or more detailed unit operations modeling during process development and scale-up in pharmaceutical synthesis and formulation (e.g. reaction steps, kinetics, solvent chasing, crystallization, filtration, drying). Particular consideration will be given to examples of model development from laboratory data with model validation during scale-up and clear savings or greater process understanding as a result of process modeling.
Chair: Richard Schild
CoChair: Christopher L. Burcham
  Application of Quality by Design Principles In the Model Predictions for Scale-up of Tablet Film Coating
Andrew Prpich, Mary T. Am Ende, Thomas Katzschner, Veronica Lubczyk, Holger Weyhers, Georg Bernhard
  Use of Molecular Modeling In the Formulation of Suspensions
Jamie T. Konkel, Allan S. Myerson
  Use of Pharmacokinetic/pharmacodynamic (PK/PD) Modeling to Aid Formulation Selection
Larissa A. Wenning, Eseng Lai, Tami Crumley, Tian-Quan Cai, Fang Liu, M. G. Waters, Shaun Fitzpatrick, Julie Stone
  Computer Aided Modelling in Pharmacokinetics as a Topical Issue
Michael Wulkow, Regina Telgmann
  Break
  Modeling of Tablet Dissolution Attendant to Tablet Microstructure Using a Multi-Process F-D Method
Dan Braido, Alberto Cuitino
  Finite Element Analysis of Tablet Compaction Using a Modified Material Plasticity Model
Tuhin Sinha, Jennifer S. Curtis, Bruno C. Hancock, Carl R. Wassgren
  Modeling of the Compaction of Confined Powder Beds Using a Modified Quasi-Continuum Approach
Athanas A. Koynov, Alberto Cuitino

See more of Food, Pharmaceutical & Bioengineering Division

See more of The 2008 Annual Meeting